Session date: 
06/29/2023 - 12:00pm to 1:00pm

PRESENTATION TITLE
Addressing the Tumor Microenvironment in Castration-Resistant Prostate Cancer 

Learning objectives
Upon completion of this activity, participants should be able to:

    1. Identify how hypoxia and ECM in bone tumor microenvironment drives drug resistance
    2. Recognize the contribution of integrins to prostate cancer etiology and drug resistance
    3. 3.  Define the mechanisms by which AR contributes to castration-resistant prostate cancer
    4. 4.  Evaluate efficacy of two new novel agents to target integrins and AR in bone-metastatic castration-resistant prostate cancer


ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Presenter: 
Cindy Miranti, Ph.D.
Where did the idea for the course originate?: 
Arizona
Please login or register to take this course.
Where did the idea for the course originate?: 
Arizona